Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Gastroenterology | Hepatology (Liver, Pancreatic, Gall Bladder)
Search Medical Condition
Liver Disease Clinical Trials
A listing of Liver Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (1341) clinical trials
TARGET-NASH: A 5-year longitudinal observational study of patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis
Data collection on patients with NAFLD/NASH to determine the natural course of the liver disease and to determine if certain lifestyle changes or diet changes that may be recommended by your doctor can affect NAFLD/NASH. Optional blood samples may be collected once a year to identify and understand the genetic ...
TARGET-PBC: A 5-year longitudinal observational study of patients with primary biliary cholangitis
Data collection study to determine if certain lifestyle changes or changes in diet or other treatments that may be recommended by your doctors can affect PBC. Researchers are interested in observing how these lifestyle changes, counseling, or other treatments work in patients who are treated by their doctors in routine ...
Effect of Hepatic and Renal Impairment on the Pharmacokinetics Safety and Tolerability of BAY1841788 (ODM-201)
Evaluate the potential effect of hepatic or renal impairment on the pharmacokinetics, safety and tolerability of BAY 1841788 (ODM-201).
A Phase 2b, Randomized, Doubl-blind, Placebo-controlled, Parallel-group, Dose-ranging-finding Trial of XXXXX Administered Orally for 8 Weeks to Patients with Symptomatic Gastroesophageal Reflux Disease Not Completely Responsive to Proton Pump Inhibitors
A study to enroll patients who have GERD and continue to experience GERD symptoms while receiving once daily proton pump inhibitors.
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)
To study the investigational drug, obeticholic acid (also known as OCA), and its effect on NASH and to find out how safe and effective OCA may be in delaying specific medical conditions or health related issues that can occur in patients with NASH and evidence of liver fibrosis. Patients will ...
If you have Chronic Obstructive Pulmonary Disease (COPD), you need to know about Alpha-1 Antitrypsin Deficiency.
What is Alpha-1 Antitrypsin Deficiency? Alpha-1 Antitrypsin Deficiency is a genetic (inherited) condition that may result in serious lung disease in adults and/or liver disease at any age. Alpha-1 Antitrypsin Deficiency occurs when there is a lack of a protein in the blood called alpha-1 antitrypsin, or AAT. AAT is ...
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who have Advanced Liver Disease or are Post-Liver Transplant
To explore the antiviral efficacy of combination therapy with sofosbuvir/ledipasvir fixed-dose combination ribavirin for 12 or 24 weeks in patients with advanced liver disease. Study designed with A cohort and B cohort.
Unexplained and Untreatable Abdominal Pain
A research study is evaluating the prevalence of Acute Hepatic Porphyria (AHP) in adults with explained and untreatable abdominal pain.
OPtical Coherence Tomography (OCT) Guided Coronary Stent IMplantation Compared to Angiography: a Multicenter Randomized TriaL in PCI - Ilumien IV
The objective of this clinical investigation is to demonstrate the superiority of an Optical Coherence Tomography (OCT)-guided stent implantation strategy compared to an angiography-guided stent implantation strategy in achieving larger post-PCI lumen dimensions and improving clinical cardiovascular outcomes in patients with high-risk clinical characteristics and/or with high-risk angiographic lesions.
Fatty Liver Research Study – Compensation up to $600
Clinical Trials of Texas, Inc. is conducting a research study of an investigational medication for participants. Qualified participants receive study-related medical care from a board-certified physician, study medications, supplies and exams.
